-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 3 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 3 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients - 3 month(s) ago
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. “Alcohol-associated hepatitis (AH) is the most severe form of liver disease on the spectrum of alcohol-associated liver disease (ALD) with high short- and long-term mortality and
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 20A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis - 3 month(s) ago
This patient’s case history (void of protected health information) was discussed in a multidisciplinary meeting including hepatologists (LD, MG), a pathologist (DK), an immunologist (EP) with NC as moderator. We summarize the case history and discussion in the following article.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Investigational HCV Therapy Demonstrates 98% Sustained Virologic Response at Week 4 - 4 month(s) ago
Atea Pharmaceuticals announced topline data from their phase 2 trial showing a higher than expected efficacy for the study.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy - 4 month(s) ago
Data on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) in migrants living in Italy are scanty,1 and there are few screening and linkage-to-care programs for this target.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Hepatitis C: The Year in Review - 5 month(s) ago
In 2023, there were numerous developments in hepatitis C including the Biden Administration’s new budget that put aside several billion dollars towards establishing a hepatitis C (HCV) program; GSK’s investigational hepatitis therapy began phase 3 trials; and the Cherokee Nation’s Hepatitis C elimination program which has worked to increase screening and get people into the continuum of care. Check out these stories and more from this year.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
According to a recent study, DAAs remain underutilized in patients with HCV-related HCC, despite improved survival outcomes.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Just 8.5% of eligible patients were screened for hepatitis C, and among them, 5.9% tested positive for HCV antibody and 3.0% had an active infection.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
An analysis of ED utilization from 2️⃣0️⃣1️⃣6️⃣ to 2️⃣0️⃣1️⃣9️⃣ revealed an increase in visits for alcohol-associated #hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity. Learn more at the 🔗 below 👇🏼 https://t.co/yxwsBQ0DmG